We are live on ! Find out more
AMIX

Autonomix Medical

14 hedge funds and large institutions have $173K invested in Autonomix Medical in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

75% more funds holding

Funds holding: 814 (+6)

20% more capital invested

Capital invested by funds: $144K → $173K (+$29K)

0.01% more ownership

Funds ownership: 0.3%0.31% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AMIX Hedge Fund Activity: Q2 2025 in Review

14 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Autonomix Medical (AMIX) for Q2 2025, worth a combined $173K — up 20% from $144K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AMIX positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $34.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $20.5K sold.

  • 14 institutional investors held Autonomix Medical (AMIX) as of Q2 2025, up from 8 in Q1 2025.
  • Funds reported $173K of Autonomix Medical stock for Q2 2025, up 20% quarter-over-quarter.
  • 8 funds opened new Autonomix Medical positions in Q2 2025 and 2 closed out, a net change of +6 holders.
  • The largest Autonomix Medical buyer in Q2 2025 was Susquehanna International Group, an estimated $34.9K added.
  • The largest Autonomix Medical seller in Q2 2025 was Citadel Advisors, an estimated $20.5K sold.

Based on aggregated 13F filings for Q2 2025.